Bazı borlu bileşiklerin anti-quorum sensing inhibitör aktivitelerinin belirlenmesi

Abstract

Bor, başta bitkiler ve bazı hayvanlar olmak üzere canlılar için önemli elementlerden biridir. Borun insanlık için önemi giderek artmakta ve kullanım alanları da buna paralel olarak genişlemektedir. Bu çalışmada, 5 farklı bor bileşiğinin quorum-sensing inhibisyon etkileri araştırılmıştır. Quorum-sensing inhibisyon deneyi CV026 ve CV12472 üzerinde broth dilüsyon yöntemi kullanılarak gerçekleştirilmiştir. Çalışma sonuçları dikkate alındığında, en yüksek violacein inhibisyon aktivitesinin %74,46 ile sodyum tetraborat tarafından sağlandığı belirlenmiştir. Quorum sensing aktivitesi baz alındığında ise bor oksit ve sodyum tetraboratın MİK değerinin %95,15 ile en yüksek inhibisyon oranını sağladığı ortaya çıkmıştır. Çalışmadan elde edilen anti-quorum sensing aktivite verileri incelendiğinde, bu bor bileşiklerinin yüksek aktivite gösterdiği ve hayvan deneyleri gibi farklı testlerle desteklenmesi gerektiği görülmektedir.

Keywords

• borlu bileşikler
• Quorum algılama inhibisyonu
• Violacein indirgenmesi

Investigation of anti-quorum sensing inhibition activity of some boron compounds

Abstract

Boron is one of the important elements for organisms, especially for plants and animals. The importance of boron for humanity is increasing, and its uses are parallelly expanding. In this study, the quorum-sensing inhibition effects of five different boron compounds were investigated. The quorum-sensing inhibition assay was performed on CV026 and CV12472 using the broth dilution method. Considering the results of this study, it was determined that the highest violacein inhibition activity was provided by sodium tetraborate with 74.46%. Based on the quorum sensing activity, it was revealed that the minimum inhibitory concentration (MIC) value of boron oxide and sodium tetraborate provided the highest inhibition rate 95.15%. When the anti-quorum sensing activity data obtained from the study are examined, it was seen that these boron compounds showed high activity and should be supported by different tests such as animal experiments.

Keywords

• boron compounds
• Quorum sensing inhibition
• Violacein reduction

References

1. [1] Jans, K., Lüersen, K., & Rimbach, G. (2021). Drosophila melanogaster as a model organism to study lithium and boron bioactivity. International Journal of Molecular Sciences, 22(21), 11710. https://doi.org/10.3390/ijms222111710
2. [2] Tombuloglu, A., Copoglu, H., Aydin-Son, Y., & Guray, N. T. (2020). In vitro effects of boric acid on human liver hepatoma cell line (HepG2) at the half-maximal inhibitory concentration. Journal of Trace Elements in Medicine and Biology, 62, 126573. https://doi.org/10.1016/j.jtemb.2020.126573
3. [3] Aydin, H. E., Koldemir Gündüz, M., Kizmazoğlu, C., Kandemir, T., & Arslantaş, A. (2021). Cytotoxic effect of boron application on glioblastoma cells. Turkish Neurosurgery, 31(2), 206-210. https://doi.org/10.5137/1019-5149.JTN.30316-20.1
4. [4] Gündüz, M. K., Bolat, M., Kaymak, G., Berikten, D., & Köse, D. A. (2022). Therapeutic effects of newly synthesized boron compounds (BGM and BGD) on hepatocellular carcinoma. Biological Trace Element Research, 200, 134-146. https://doi.org/10.1007/s12011-021-02647-9
5. [5] Ali, F., Hosmane, N. S., & Zhu, Y. (2020). Boron chemistry for medical applications. Molecules, 25(4), 828. https://doi.org/10.3390/molecules25040828
6. [6] Yakin, A., Avar, B., Simsek, T., & Chattopadhyay, A. K. (2023). Synthesis of boron-based alloys and compounds by mechanical alloying: A review. Materials Today Communications, 37, 106980. https://doi.org/10.1016/j.mtcomm.2023.106980
7. [7] Prazdnova, E. V., Gorovtsov, A. V., Vasilchenko, N. G., Kulikov, M. P., Statsenko, V. N., Bogdanova, A. A., … & Chikindas, M. L. (2022). Quorum-sensing inhibition by gram-positive bacteria. Microorganisms, 10(2), 350. https://doi.org/10.3390/microorganisms10020350
8. [8] Aydin, H. E., Gunduz, M. K., Kizmazoglu, C., Kandemir, T., & Arslantas, A. (2021). Cytotoxic effect of boron application on glioblastoma cells. Turkish Neurosurgery, 31(2), 206-210. https://doi.org/10.5137/1019-5149.JTN.30316-20.1

9. [9] Koldemir-Gündüz, M., Aydin, H. E., Berikten, D., Kaymak, G., Köse, D. A., & Arslantaş, A. (2021). Synthesis of new boron derived compounds; anticancer, antioxidant and antimicrobial effect in vitro glioblastoma tumor model. Journal of Korean Neurosurgical Society, 64(6), 864-872. https://doi.org/10.3340/jkns.2021.0032
10. [10] Meiyanto, E., Susidarti, R. A., Jenie, R. I., Utomo, R. Y., Novitasari, D., Wulandari, F., & Kirihata, M. (2020). Synthesis of new boron containing compound (CCB-2) based on curcumin structure and its cytotoxic effect against cancer cells. Journal of Applied Pharmaceutical Science, 10(2), 060-066. https://doi.org/10.7324/JAPS.2020.102010
11. [11] Barrón-González, M., Montes-Aparicio, A. V., Cuevas-Galindo, M. E., Orozco-Suárez, S., Barrientos, R., Alatorre, A., … & Soriano-Ursúa, M. A. (2023). Boroncontaining compounds on neurons: Actions and potential applications for treating neurodegenerative diseases. Journal of Inorganic Biochemistry, 238, 112027. https://doi.org/10.1016/j.jinorgbio.2022.112027
12. [12] Gündüz, M. K., Bolat, M., Kaymak, G., Berikten, D., & Köse, D. A. (2022). Therapeutic effects of newly synthesized boron compounds (BGM and BGD) on hepatocellular carcinoma. Biological Trace Element Research, 200, 134-146. https://doi.org/10.1007/s12011-021-02647-9
13. [13] Kahriman, N., Haşimoğlu, Z., Serdaroğlu, V., Beriş, F. Ş., Barut, B., & Yaylı, N. (2017). Synthesis of novel pyrazolines, their boron-fluorine complexes, and investigation of antibacterial, antioxidant, and enzyme inhibition activities. Archiv der Pharmazie, 350(2), 1600285. https://doi.org/10.1002/ardp.201600285
14. [14] Espinel-Ingroff, A., Fothergill, A., Ghannoum, M., Manavathu, E., Ostrosky-Zeichner, L., Pfaller, M., ... & Walsh, T. (2005). Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole. Journal of Clinical Microbiology, 45(7). https://doi.org/10.1128/jcm.00399-07
15. [15] Tamfu, A. N., Ceylan, O., Fru, G. C., Ozturk, M., Duru, M. E., & Shaheen, F. (2020). Antibiofilm, antiquorum sensing and antioxidant activity of secondary metabolites from seeds of Annona senegalensis, Persoon. Microbial Pathogenesis, 144, 104191. https://doi.org/10.1016/j.micpath.2020.104191
16. [16] Ceylan, O., Tamfu, A.N., Doğaç, Y.İ., & Teke, M. (2020). Antibiofilm and anti-quorum sensing activities of polyethylene imine coated magnetite and nickel ferrite nanoparticles. 3 Biotech, 10, 513. https://doi.org/10.1007/s13205-020-02509-6
17. [17] Fink, K., & Uchman, M. (2021). Boron cluster compounds as new chemical leads for antimicrobial therapy. Coordination Chemistry Reviews, 431, 213684. https://doi.org/10.1016/j.ccr.2020.213684
18. [18] Celebi, O., Celebi, D., Baser, S., Aydın, E., Rakıcı, E., Uğraş, S., … & Abd El-Aty, A. M. (2024). Antibacterial activity of boron compounds against biofilm-forming pathogens. Biological Trace Element Research, 202, 346-359. https://doi.org/10.1007/s12011-023-03768-z
19. [19] Baygar, T., Saraç, N., Ceylan, Ö., Uğur, A., Boran, R., & Balcı, U. (2022). In vitro biological activities of potassium metaborate; antioxidative, antimicrobial and antibiofilm properties. Journal of Boron, 7(2), 475-481. https://doi.org/10.30728/boron.1076636
20. [20] Boran, R., Baygar, T., Saraç, N., Ayrıkçil, S., Yılmaz, D., & Uğur, A. (2023). Antimicrobial, antifibrinolytic, enzyme inhibitory and wound healing properties of zinc borate. Journal of Boron, 8(3), 99-104. https://doi.org/10.30728/boron.1180847
21. [21] Bali, E. B., Türkmen, K. E., Erdönmez, D., & Sağlam, N. (2019). Comparative study of inhibitory potential of dietary phytochemicals against quorum sensing activity of and biofilm formation by Chromobacterium violaceum 12472, and swimming and swarming behaviour of Pseudomonas aeruginosa PAO1. Food Technology and Biotechnology, 57(2), 212. https://doi.org/10.17113/ftb.57.02.19.5823
22. [22] Durán, N., Justo, G. Z., Durán, M., Brocchi, M., Cordi, L., Tasic, L., … & Nakazato, G. (2016). Advances in Chromobacterium violaceum and properties of violacein-Its main secondary metabolite: A review. Biotechnology Advances, 34(5), 1030-1045. https://doi.org/10.1016/j.biotechadv.2016.06.003
23. [23] Kothari, V., Sharma, S., & Padia, D. (2017). Recent research advances on Chromobacterium violaceum. Asian Pacific Journal of Tropical Medicine, 10(8), 744-752. https://doi.org/10.1016/j.apjtm.2017.07.022
24. [24] Krzyżek, P. (2019). Challenges and limitations of antiquorum sensing therapies. Frontiers in Microbiology, 10, 2473. https://doi.org/10.3389/fmicb.2019.02473
25. [25] Alisjahbana, B., Debora, J., Susandi, E., & Darmawan, G. (2021). Chromobacterium violaceum: A review of an unexpected scourge. International Journal of General Medicine, 14, 3259-3270. https://doi.org/10.2147/IJGM.S272193
26. [26] Temel, H., Atlan, M., Türkmenoğlu, B., Ertaş, A., Erdönmez, D., & Çalışkan, U. K. (2023). In silico and biological activity evaluation of quercetin-boron hybrid compounds, anti-quorum sensing effect as alternative potential against microbial resistance. Journal of Trace Elements in Medicine and Biology, 77, 127139. https://doi.org/10.1016/j.jtemb.2023.127139
27. [27] Çelebi, Ö., Başer, S., Balkan Bozlak, Ç. E., Taghizadehghalehjoughi, A., Mahmoudnezhad, A., & Celebi, D. (2023). Boron compounds with antibiofilm and synergistic effects on Escherichia coli infection. Kafkas Journal of Medical Sciences, 13(3), 271-278. https://doi.org/10.5505/kjms.2023.22605
28. [28] Sevim, Ç., Ozkaraca, M., Kara, M., Taghizadehghalehjoughi, A., Genç, S., Yeni, Y., … & Tsatsakis, A. (2025). Exploring the anti‑inflammatory activity of boron compounds through the miR‑21/PTEN/AKT pathway in cecal ligation and puncture‑induced sepsis. Molecular Medicine Reports, 31(2), 52. https://doi.org/10.3892/mmr.2024.13417
29. [29] Temel, H., Atlan, M., Ertas, A., Yener, I., Akdeniz, M., Yazan, Z., … & Akyuz, E. (2022). Cream production and biological in vivo/in vitro activity assessment of a novel boron-based compound derived from quercetin and phenyl boronic acid. Journal of Trace Elements in Medicine and Biology, 74, 127073. https://doi.org/10.1016/j.jtemb.2022.127073
30. [30] Sedighi-Pirsaraei, N., Tamimi, A., Sadeghi Khamaneh, F., Dadras-Jeddi, S., & Javaheri, N. (2024). Boron in wound healing: A comprehensive investigation of its diverse mechanisms. Frontiers in Bioengineering and Biotechnology, 12, 1475584. https://doi.org/10.3389/fbioe.2024.1475584
31. [31] Romero-Aguilar, K. S., Arciniega-Martínez, I. M., Farfán- García, E. D., Campos-Rodríguez, R., Reséndiz-Albor, A. A., & Soriano-Ursúa, M. A. (2019). Effects of boroncontaining compounds on immune responses: Review and patenting trends. Expert Opinion on Therapeutic Patents, 29(5), 339-351. https://doi.org/10.1080/13543776.2019.1612368
32. [32] Yildirim, M., Kilic, A., Cimentepe, M., Necip, A., & Turedi, S. (2025). Synthesis of bioactive quercetin-boronate esters as a novel biological agent: Enzyme inhibition, anti-microbial properties, computational insights and anti-cancer activity. Journal of Molecular Structure, 1321, 140216. https://doi.org/10.1016/j.molstruc.2024.140216